Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
mpox
Biotech
Bavarian Nordic halts cancer vaccine program
Bavarian Nordic may be celebrating its most profitable year yet, but that hasn’t stopped the Danish biotech from streamlining its portfolio.
James Waldron
Feb 21, 2024 7:25am
BioNTech pockets $90M from CEPI to partner on mpox vaccine
Sep 18, 2023 10:30am
Cheaper, faster, simpler: Is a new mpox vaccine on the horizon?
Jul 18, 2023 3:03am
Evotec's latest DOD contract provides $74M to tackle mpox
Jul 5, 2023 10:00am
BIO: Moderna to test mpox vaccine in humans this summer
Jun 7, 2023 9:25am